Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
PaperCitations, authors & open-access status
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 136 citations, 2024 year and closed oa status.
136
Citations
2024
Year
closed
OA Status